Data Insights

By Company Name

By Disease Name

By Drug Name

By Themes

Showing 4 results out of 4

Company Profiles

Access comprehensive reports covering all the major players in the pharmaceutical industry

Gain a competitive edge
Enhance your sales strategy
Get forward-looking insights
Support your decision making

Buy Now

Data Insights

Epinephrine by ARS Pharmaceuticals for Anaphylaxis: Likelihood of Approval

Epinephrine is under clinical development by ARS Pharmaceuticals and currently in Pre-Registration for Anaphylaxis. According to GlobalData, Pre-Registration drugs for...

Likelihood of Approval and Phase Transition Success Rate Model - Epinephrine in Anaphylaxis

Data Insights

Risk adjusted net present value: What is the current valuation of Aquestive Therapeutics's Epinephrine?

Epinephrine is a small molecule commercialized by Aquestive Therapeutics, with a leading Phase III program in Anaphylaxis. According to Globaldata,...

Net Present Value Model: Aquestive Therapeutics Inc's Epinephrine

Data Insights

Epinephrine by ARS Pharmaceuticals for Chronic Urticaria Or Hives: Likelihood of Approval

Epinephrine is under clinical development by ARS Pharmaceuticals and currently in Phase II for Chronic Urticaria Or Hives. According to...

Likelihood of Approval and Phase Transition Success Rate Model - Epinephrine in Chronic Urticaria Or Hives

Data Insights

Epinephrine by ARS Pharmaceuticals for Infectious Rhinitis: Likelihood of Approval

Epinephrine is under clinical development by ARS Pharmaceuticals and currently in Phase I for Infectious Rhinitis. According to GlobalData, Phase...

Likelihood of Approval and Phase Transition Success Rate Model - Epinephrine in Infectious Rhinitis